Format
Sort by
Items per page

Send to

Choose Destination

Best matches for König F[au]:

Versorgungsforschung in der Uroonkologie – Von der Last zur Lust auf Daten. König F et al. Aktuelle Urol. (2018)

In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and <i>KRAS</i> Point Mutations in Circulating Tumor Cells. El-Heliebi A et al. Clin Chem. (2018)

Diffusion-weighted breast imaging. Deike-Hofmann K et al. Radiologe. (2018)

Search results

Items: 1 to 50 of 227

1.

A three-dimensional intestinal tissue model reveals factors and small regulatory RNAs important for colonization with Campylobacter jejuni.

Alzheimer M, Svensson SL, König F, Schweinlin M, Metzger M, Walles H, Sharma CM.

PLoS Pathog. 2020 Feb 18;16(2):e1008304. doi: 10.1371/journal.ppat.1008304. [Epub ahead of print]

2.

Advanced Diffusion-Weighted Abdominal Imaging: Qualitative and Quantitative Comparison of High and Ultra-High b-Values for Lesion Detection and Image Quality.

Dreher C, Kuder TA, König F, Paech D, Tavakoli A, Laun FB, Flothow F, Gnirs R, Benkert T, Strecker R, Schlemmer HP, Bickelhaupt S.

Invest Radiol. 2020 Jan 31. doi: 10.1097/RLI.0000000000000639. [Epub ahead of print]

PMID:
32011572
3.

Single-reviewer abstract screening missed 13 percent of relevant studies: a crowd-based, randomized controlled trial.

Gartlehner G, Affengruber L, Titscher V, Noel-Storr A, Dooley G, Ballarini N, König F.

J Clin Epidemiol. 2020 Jan 21;121:20-28. doi: 10.1016/j.jclinepi.2020.01.005. [Epub ahead of print]

4.

[Radium-223 for the treatment of metastatic castration-resistant prostate cancer (mCRPC) : The androgen receptor-independent active agent in the therapeutic sequence].

König F, Strauß A, Johannsen M, Mommsen C, Fricke E, Klier J, Mehl S, Pfister D, Sahlmann CO, Werner A, Goebell PJ.

Urologe A. 2020 Jan;59(1):53-64. doi: 10.1007/s00120-019-01052-4. Review. German.

PMID:
31598745
5.

A multiple comparison procedure for dose-finding trials with subpopulations.

Thomas M, Bornkamp B, Posch M, König F.

Biom J. 2020 Jan;62(1):53-68. doi: 10.1002/bimj.201800111. Epub 2019 Sep 23.

6.

Detection of Androgen Receptor Variant 7 (ARV7) mRNA Levels in EpCAM-Enriched CTC Fractions for Monitoring Response to Androgen Targeting Therapies in Prostate Cancer.

Hille C, Gorges TM, Riethdorf S, Mazel M, Steuber T, Amsberg GV, König F, Peine S, Alix-Panabières C, Pantel K.

Cells. 2019 Sep 11;8(9). pii: E1067. doi: 10.3390/cells8091067.

7.

Induction of Articular Chondrogenesis by Chitosan/Hyaluronic-Acid-Based Biomimetic Matrices Using Human Adipose-Derived Stem Cells.

Huang Y, Seitz D, König F, Müller PE, Jansson V, Klar RM.

Int J Mol Sci. 2019 Sep 11;20(18). pii: E4487. doi: 10.3390/ijms20184487.

8.

Generation of microbubbles in extracorporeal life support and assessment of new elimination strategies.

Born F, König F, Chen J, Günther S, Hagl C, Thierfelder N.

Artif Organs. 2020 Mar;44(3):268-277. doi: 10.1111/aor.13557. Epub 2019 Sep 30.

PMID:
31408537
9.

Modulating Diffusion-Weighted Magnetic Resonance Imaging for Screening in Oncologic Tertiary Prevention: A Prospective Ex Vivo and In Vivo Study.

Dreher C, Kuder TA, König F, Paech D, Tavakoli A, Laun FB, Flothow F, Gnirs R, Benkert T, Nickel D, Strecker R, Schlemmer HP, Bickelhaupt S.

Invest Radiol. 2019 Nov;54(11):704-711. doi: 10.1097/RLI.0000000000000596.

PMID:
31356384
10.

De Novo Emergence of Peptides That Confer Antibiotic Resistance.

Knopp M, Gudmundsdottir JS, Nilsson T, König F, Warsi O, Rajer F, Ädelroth P, Andersson DI.

mBio. 2019 Jun 4;10(3). pii: e00837-19. doi: 10.1128/mBio.00837-19.

11.

[Diffusion-weighted imaging-diagnostic supplement or alternative to contrast agents in early detection of malignancies?]

Bickelhaupt S, Dreher C, König F, Deike-Hofmann K, Paech D, Schlemmer HP, Kuder TA.

Radiologe. 2019 Jun;59(6):517-522. doi: 10.1007/s00117-019-0532-7. Review. German.

PMID:
31065738
12.

Interim analysis incorporating short- and long-term binary endpoints.

Niewczas J, Kunz CU, König F.

Biom J. 2019 May;61(3):665-687. doi: 10.1002/bimj.201700281. Epub 2019 Jan 29.

13.

Nested combination tests with a time-to-event endpoint using a short-term endpoint for design adaptations.

Jörgens S, Wassmer G, König F, Posch M.

Pharm Stat. 2019 May;18(3):329-350. doi: 10.1002/pst.1926. Epub 2019 Jan 16.

PMID:
30652401
14.

Pericardial tissue for cardiovascular application: an in-vitro evaluation of established and advanced production processes.

Grefen L, König F, Grab M, Hagl C, Thierfelder N.

J Mater Sci Mater Med. 2018 Nov 3;29(11):172. doi: 10.1007/s10856-018-6186-6.

PMID:
30392024
15.

A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.

Vychytil A, Herzog R, Probst P, Ribitsch W, Lhotta K, Machold-Fabrizii V, Wiesholzer M, Kaufmann M, Salmhofer H, Windpessl M, Rosenkranz AR, Oberbauer R, König F, Kratochwill K, Aufricht C.

Kidney Int. 2018 Dec;94(6):1227-1237. doi: 10.1016/j.kint.2018.08.031. Epub 2018 Oct 22.

16.

Subgroup identification in clinical trials via the predicted individual treatment effect.

Ballarini NM, Rosenkranz GK, Jaki T, König F, Posch M.

PLoS One. 2018 Oct 18;13(10):e0205971. doi: 10.1371/journal.pone.0205971. eCollection 2018.

17.

Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4).

Beach TG, Serrano GE, Kremer T, Canamero M, Dziadek S, Sade H, Derkinderen P, Corbillé AG, Letournel F, Munoz DG, White CL 3rd, Schneider J, Crary JF, Sue LI, Adler CH, Glass MJ, Intorcia AJ, Walker JE, Foroud T, Coffey CS, Ecklund D, Riss H, Goßmann J, König F, Kopil CM, Arnedo V, Riley L, Linder C, Dave KD, Jennings D, Seibyl J, Mollenhauer B, Chahine L; Systemic Synuclein Sampling Study (S4).

J Neuropathol Exp Neurol. 2018 Sep 1;77(9):793-802. doi: 10.1093/jnen/nly056.

18.

Diffusion-weighted breast imaging.

Deike-Hofmann K, Kuder T, König F, Paech D, Dreher C, Delorme S, Schlemmer HP, Bickelhaupt S.

Radiologe. 2018 Nov;58(Suppl 1):14-19. doi: 10.1007/s00117-018-0423-3.

PMID:
30003283
19.

[Advanced Prostate Cancer Consensus Conference 2017 : Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts].

Schostak M, König F, Bögemann M, Goebell P, Hammerer P, Machtens S, Schwentner C, Thomas C, von Amsberg G, von Rundstedt FC, Heidenreich A.

Urologe A. 2018 Jul;57(7):813-820. doi: 10.1007/s00120-018-0680-9. German.

PMID:
29808368
20.

Lessons learned from IDeAl - 33 recommendations from the IDeAl-net about design and analysis of small population clinical trials.

Hilgers RD, Bogdan M, Burman CF, Dette H, Karlsson M, König F, Male C, Mentré F, Molenberghs G, Senn S.

Orphanet J Rare Dis. 2018 May 11;13(1):77. doi: 10.1186/s13023-018-0820-8. Review.

21.

Mechanical characteristics of beta sheet-forming peptide hydrogels are dependent on peptide sequence, concentration and buffer composition.

Koch F, Müller M, König F, Meyer N, Gattlen J, Pieles U, Peters K, Kreikemeyer B, Mathes S, Saxer S.

R Soc Open Sci. 2018 Mar 14;5(3):171562. doi: 10.1098/rsos.171562. eCollection 2018 Mar.

22.

Versorgungsforschung in der Uroonkologie – Von der Last zur Lust auf Daten.

König F, Johannsen M, Klier J, Schönfelder R, Eichenauer R, Rexer H, Gschwend J, Suttmann H, Doehn C.

Aktuelle Urol. 2018 Apr;49(2):125. doi: 10.1055/s-0044-101694. Epub 2018 Mar 27. German. No abstract available.

PMID:
29587317
23.

In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells.

El-Heliebi A, Hille C, Laxman N, Svedlund J, Haudum C, Ercan E, Kroneis T, Chen S, Smolle M, Rossmann C, Krzywkowski T, Ahlford A, Darai E, von Amsberg G, Alsdorf W, König F, Löhr M, de Kruijff I, Riethdorf S, Gorges TM, Pantel K, Bauernhofer T, Nilsson M, Sedlmayr P.

Clin Chem. 2018 Mar;64(3):536-546. doi: 10.1373/clinchem.2017.281295. Epub 2018 Jan 4.

PMID:
29301749
24.

Optimized adaptive enrichment designs.

Ondra T, Jobjörnsson S, Beckman RA, Burman CF, König F, Stallard N, Posch M.

Stat Methods Med Res. 2019 Jul;28(7):2096-2111. doi: 10.1177/0962280217747312. Epub 2017 Dec 18.

25.

RANKL/RANK/OPG cytokine receptor system: mRNA expression pattern in BPH, primary and metastatic prostate cancer disease.

Christoph F, König F, Lebentrau S, Jandrig B, Krause H, Strenziok R, Schostak M.

World J Urol. 2018 Feb;36(2):187-192. doi: 10.1007/s00345-017-2145-y. Epub 2017 Dec 4.

PMID:
29204705
26.

The cardiotomy reservoir - a preliminary evaluation of a new cell source for cardiovascular tissue engineering.

von Nathusius S, König F, Sodian R, Born F, Hagl C, Thierfelder N.

Int J Artif Organs. 2017 Nov 21:0. doi: 10.5301/ijao.5000653. [Epub ahead of print]

PMID:
29192716
27.

[Metastatic castration-resistant prostate cancer : Use of cabazitaxel taking into consideration current data].

Gschwend JE, Albers P, Bögemann M, Goebell P, Heidenreich A, Klier J, König F, Machtens S, Pantel K, Thomas C.

Urologe A. 2018 Jan;57(1):34-39. doi: 10.1007/s00120-017-0533-y. German.

PMID:
29071398
29.

Clearance of Selected Plasma Cytokines with Continuous Veno-Venous Hemodialysis Using Ultraflux EMiC2 versus Ultraflux AV1000S.

Eichhorn T, Hartmann J, Harm S, Linsberger I, König F, Valicek G, Miestinger G, Hörmann C, Weber V.

Blood Purif. 2017;44(4):260-266. doi: 10.1159/000478965. Epub 2017 Oct 7.

PMID:
28988232
30.

[Thermochemotherapy with Mitomycin C: an update on alternative treatment strategies in non-muscleinvasive bladder cancer].

Christoph F, König F, Lebentrau S, Blaschke S, Liehr UB, Schostak M.

Aktuelle Urol. 2018 Apr;49(2):157-163. doi: 10.1055/s-0043-109414. Epub 2017 Sep 19. Review. German.

PMID:
28926864
31.

Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.

Jarius S, König FB, Metz I, Ruprecht K, Paul F, Brück W, Wildemann B.

J Neuroinflammation. 2017 Aug 29;14(1):171. doi: 10.1186/s12974-017-0929-z.

32.

[Metastatic prostate cancer : Update: position paper for the use of chemotherapy].

Ohlmann CH, Goebell PJ, Grimm MO, Klier J, König F, Machtens S, Schostak M, Schrader AJ, Albers P.

Urologe A. 2017 Dec;56(12):1597-1602. doi: 10.1007/s00120-017-0459-4. Review. German.

PMID:
28695241
33.

[Prostate gland - what would urologists like to know from radiologists?]

Liehr UB, Baumunk D, Blaschke S, Fischbach F, Friebe B, König F, Lemke A, Mittelstädt P, Pech M, Porsch M, Ricke J, Schindele D, Siedentopf S, Wendler JJ, Schostak M.

Radiologe. 2017 Aug;57(8):608-614. doi: 10.1007/s00117-017-0273-4. Review. German.

PMID:
28660295
34.

The monoclonal S9.6 antibody exhibits highly variable binding affinities towards different R-loop sequences.

König F, Schubert T, Längst G.

PLoS One. 2017 Jun 8;12(6):e0178875. doi: 10.1371/journal.pone.0178875. eCollection 2017.

35.

A prospective study investigating the impact of multiparametric MRI in biopsy-naïve patients with clinically suspected prostate cancer: The PROKOMB study.

Baur ADJ, Henkel T, Johannsen M, Speck T, Weißbach L, Hamm B, König F.

Contemp Clin Trials. 2017 May;56:46-51. doi: 10.1016/j.cct.2017.03.001. Epub 2017 Mar 6.

PMID:
28279782
36.

Effect of hypoxia on the proliferation of porcine bone marrow-derived mesenchymal stem cells and adipose-derived mesenchymal stem cells in 2- and 3-dimensional culture.

Burian E, Probst F, Palla B, Riedel C, Saller MM, Cornelsen M, König F, Schieker M, Otto S.

J Craniomaxillofac Surg. 2017 Mar;45(3):414-419. doi: 10.1016/j.jcms.2016.12.014. Epub 2016 Dec 20.

PMID:
28110999
37.

Tissue-engineering acellular scaffolds-The significant influence of physical and procedural decellularization factors.

Starnecker F, König F, Hagl C, Thierfelder N.

J Biomed Mater Res B Appl Biomater. 2018 Jan;106(1):153-162. doi: 10.1002/jbm.b.33816. Epub 2016 Nov 29.

PMID:
27898187
38.

Chronic stress leads to epigenetic dysregulation in the neuropeptide-Y and cannabinoid CB1 receptor genes in the mouse cingulate cortex.

Lomazzo E, König F, Abassi L, Jelinek R, Lutz B.

Neuropharmacology. 2017 Feb;113(Pt A):301-313. doi: 10.1016/j.neuropharm.2016.10.008. Epub 2016 Oct 11.

PMID:
27737789
39.

In-depth neuropharmacokinetic analysis of antipsychotics based on a novel approach to estimate unbound target-site concentration in CNS regions: link to spatial receptor occupancy.

Loryan I, Melander E, Svensson M, Payan M, König F, Jansson B, Hammarlund-Udenaes M.

Mol Psychiatry. 2016 Nov;21(11):1527-1536. doi: 10.1038/mp.2015.229. Epub 2016 Jan 26.

PMID:
26809840
40.

Estimation after blinded sample size reassessment.

Posch M, Klinglmueller F, König F, Miller F.

Stat Methods Med Res. 2018 Jun;27(6):1830-1846. doi: 10.1177/0962280216670424. Epub 2016 Oct 2.

41.

Optimizing Trial Designs for Targeted Therapies.

Ondra T, Jobjörnsson S, Beckman RA, Burman CF, König F, Stallard N, Posch M.

PLoS One. 2016 Sep 29;11(9):e0163726. doi: 10.1371/journal.pone.0163726. eCollection 2016.

42.

Nephron sparing surgery for renal cell carcinoma up to 7 cm in the context of guideline development: a contribution of healthcare research.

Lebentrau S, Rauter S, Baumunk D, Christoph F, König F, May M, Schostak M.

World J Urol. 2017 May;35(5):753-759. doi: 10.1007/s00345-016-1905-4. Epub 2016 Aug 12.

PMID:
27520385
43.

MALDI imaging mass spectrometry analysis-A new approach for protein mapping in multiple sclerosis brain lesions.

Maccarrone G, Nischwitz S, Deininger SO, Hornung J, König FB, Stadelmann C, Turck CW, Weber F.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Mar 15;1047:131-140. doi: 10.1016/j.jchromb.2016.07.001. Epub 2016 Jul 1.

PMID:
27461358
44.

[Metastatic castration-resistant prostate cancer : Clinical data, new treatment options and therapy monitoring].

Miller K, Albers P, Eichenauer R, Geiges G, Grimm MO, König F, Mickisch G, Pfister D, Schwentner C, Suttmann H, Zastrow S.

Urologe A. 2016 Sep;55(9):1206-12. doi: 10.1007/s00120-016-0176-4. Review. German.

PMID:
27411995
45.

Adaptive paediatric investigation plans, a small step to improve regulatory decision making in drug development for children?

Bauer P, König F.

Pharm Stat. 2016 Sep;15(5):384-6. doi: 10.1002/pst.1762. Epub 2016 Jul 12.

PMID:
27400890
46.

Degeneration and Instability and the Relation to Patients' Function Late After Lumbar Disc Surgery: Data from a 12-Year Follow-Up.

Ebenbichler GR, Leitgeb J, Amtmann G, König F, Schernthaner M, Resch KL, Kainberger F.

Am J Phys Med Rehabil. 2016 Dec;95(12):871-879.

PMID:
27149592
47.

Heterogeneous PSMA expression on circulating tumor cells: a potential basis for stratification and monitoring of PSMA-directed therapies in prostate cancer.

Gorges TM, Riethdorf S, von Ahsen O, Nastał Y P, Röck K, Boede M, Peine S, Kuske A, Schmid E, Kneip C, König F, Rudolph M, Pantel K.

Oncotarget. 2016 Jun 7;7(23):34930-41. doi: 10.18632/oncotarget.9004.

48.

Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study.

Eskandary F, Bond G, Kozakowski N, Regele H, Marinova L, Wahrmann M, Kikić Ž, Haslacher H, Rasoul-Rockenschaub S, Kaltenecker CC, König F, Hidalgo LG, Oberbauer R, Halloran PF, Böhmig GA.

Transplantation. 2017 Mar;101(3):631-641. doi: 10.1097/TP.0000000000001195.

PMID:
27120452
49.

Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.

Jarius S, Metz I, König FB, Ruprecht K, Reindl M, Paul F, Brück W, Wildemann B.

Mult Scler. 2016 Oct;22(12):1541-1549. Epub 2016 Feb 11.

PMID:
26869529
50.

[Advanced Prostate Cancer Consensus Conference (APCCC) 2015 in St. Gallen : Critical review of the recommendations on diagnosis and therapy of metastatic prostate cancer by a German expert panel].

Thomas C, Bögemann M, König F, Machtens S, Schostak M, Steuber T, Heidenreich A.

Urologe A. 2016 Jun;55(6):772-82. doi: 10.1007/s00120-016-0030-8. Review. German.

PMID:
26820660

Supplemental Content

Support Center